Roman DBDR Acquisition Corp. II
Roman DBDR Acquisition Corp. II Fundamental Analysis
Roman DBDR Acquisition Corp. II (DRDBW) shows weak financial fundamentals with a PE ratio of 35.87, profit margin of 0.00%, and ROE of 2.93%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 39.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze DRDBW's fundamental strength across five key dimensions:
Efficiency Score
WeakDRDBW struggles to generate sufficient returns from assets.
Valuation Score
ModerateDRDBW shows balanced valuation metrics.
Growth Score
WeakDRDBW faces weak or negative growth trends.
Financial Health Score
ExcellentDRDBW maintains a strong and stable balance sheet.
Profitability Score
WeakDRDBW struggles to sustain strong margins.
Key Financial Metrics
Is DRDBW Expensive or Cheap?
P/E Ratio
DRDBW trades at 35.87 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, DRDBW's PEG of 0.77 indicates potential undervaluation.
Price to Book
The market values Roman DBDR Acquisition Corp. II at 1.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 161.61 times EBITDA. This signals the market has high growth expectations.
How Well Does DRDBW Make Money?
Net Profit Margin
For every $100 in sales, Roman DBDR Acquisition Corp. II keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.93 in profit for every $100 of shareholder equity.
ROA
Roman DBDR Acquisition Corp. II generates $2.80 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.03 in free cash annually.
FCF Yield
DRDBW converts -0.31% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
35.87
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.77
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.004
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.75
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.03
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
-0.01
vs 25 benchmark
How DRDBW Stacks Against Its Sector Peers
| Metric | DRDBW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 35.87 | 19.28 | Worse (Expensive) |
| ROE | 2.93% | 792.00% | Weak |
| Net Margin | 0.00% | 2238.00% | Weak |
| Debt/Equity | 0.00 | 0.85 | Strong (Low Leverage) |
| Current Ratio | 1.75 | 604.98 | Neutral |
| ROA | 2.80% | -20889.00% (disorted) | Weak |
DRDBW outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Roman DBDR Acquisition Corp. II's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical